DRIO 0.92 (-11.54%)
US23725P2092Medical Diagnostics & ResearchDiagnostics & Research

DarioHealth (DRIO) Competitor Comparison

We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.

Total Rank - DRIO ranking 40 / 58

These are the competitors of DarioHealth in the industry Diagnostics & Research ranked by total rank
1. Laboratory Corp of America Holdings LH
4
2. Charles River Laboratories CRL
4
3. Quest Diagnostics DGX
4
4. Icon ICLR
3
5. Waters WAT
3
6. Medpace Holdings MEDP
3
7. Illumina ILMN
3
8. Syneos Health SYNH
3
9. PerkinElmer PKI
3
10. RadNet RDNT
3
11. Mettler-Toledo MTD
3
12. Global Cord Blood CO
3
13. Qiagen QGEN
3
14. bioAffinity Technologies BIAF
3
15. Danaher DHR
3
16. Inotiv NOTV
2
17. Interpace Biosciences IDXG
2
18. IQVIA Holdings IQV
2
19. Lantheus Holdings LNTH
2
20. MaxCyte MXCT
2
21. MDxHealth MDXH
2
22. Meridian Bioscience VIVO
2
23. Myriad Genetics MYGN
2
24. Natera NTRA
2
25. National Research NRC
2
26. Neogen NEOG
2
27. NeoGenomics NEO
2
28. Neuronetics STIM
2
29. Olink Holding OLK
2
30. Organovo Holdings ONVO
2
31. Ortho Clinical Diagnostics Holdings OCDX
2
32. Prenetics Global PRE
2
33. Psychemedics PMD
2
34. Exagen XGN
2
35. Anixa Biosciences ANIX
2
36. Biodesix BDSX
2
37. Bioventus BVS
2
38. CareDx CDNA
2
39. Co-Diagnostics CODX
2
40. DarioHealth DRIO
2
41. DexCom DXCM
2
42. Enzo Biochem ENZ
2
43. Exact Sciences EXAS
2
44. Agilent Technologies A
2
45. Fulgent Genetics FLGT
2
46. Guardant Health GH
2
47. Heska HSKA
2
48. IDEXX Laboratories IDXX
2
49. Sera Prognostics SERA
2
50. Sotera Health SHC
2
51. Thermo Fisher Scientific TMO
2
52. Trinity Biotech TRIB
2
53. Twist Bioscience TWST
2
54. Precipio PRPO
1
55. Personalis PSNL
1
56. SeqLL SQL
1
57. Pacific Biosciences of California PACB
1
58. Aspira Womens Health AWH
1

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.